Technically speaking this isn't true, it is a requirement of clinical evaluation and risk analysis by European regulations. The key difference is that European regulators look a lot less closely at the actual clinical data, and more closely at the evaluation process used by manufacturers.
RAP media thread., page-1639
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #